2017 Regular Session
|At the request of:
|Relating to the program used to monitor the dispensing of prescription drugs; declaring an emergency.
|Requires pharmacy to report de-identified information to prescription monitoring program upon dispensing prescribed naloxone.
|May Have Fiscal Impact, But No Statement Yet Issued
|May Have Revenue Impact, But No Statement Yet Issued
|Staff Measure Summary / Impact Statements
|In House Committee
|House Committee On Health Care
|Potential Conflicts of Interest/Vote Explanations:
|Potential Conflicts of Interest/Vote Explanation Documents